Abca3 haploinsufficiency is a risk factor for lung injury induced by hyperoxia or mechanical ventilation in a murine model

Pediatric Research

Volumn 74, Issue 4, 2013, Pages 384-392

  Herber Jonat, Susanne ^a   Mittal, Rashmi ^a   Huppmann, Marceline ^a   Hammel, Markus ^a   Liebisch, Gerhard ^b   Yildirim, Ali Önder ^c,d   Eickelberg, Oliver ^c,d   Schmitz, Gerd ^b   Hrabé De Angelis, Martin ^d,e   Flemmer, Andreas W ^a   Holzinger, Andreas ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A3; INTERLEUKIN DERIVATIVE; UNCLASSIFIED DRUG;

AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; HAPLOINSUFFICIENCY; HYPEROXIA; LUNG ALVEOLUS; LUNG INJURY; LUNG LAVAGE; LUNG MECHANICS; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; TOTAL LUNG CAPACITY;

ANALYSIS OF VARIANCE; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, WESTERN; BRONCHOALVEOLAR LAVAGE FLUID; DNA PRIMERS; GENETIC PREDISPOSITION TO DISEASE; HAPLOINSUFFICIENCY; HISTOLOGICAL TECHNIQUES; HYPEROXIA; INTERLEUKINS; LUNG; LUNG COMPLIANCE; MICE; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLGLYCEROLS; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 84885624127     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2013.127     Document Type: Article

References (34)

1. Yamano G, Funahashi H, Kawanami O, et al. ABCA3 is a lamellar body membrane protein in human lung alveolar type II cells. FEBS Lett 2001;508:221-5. (Pubitemid 33079249)
2. Garmany TH, Moxley MA, White F V, et al. Surfactant composition and function in patients with ABCA3 mutations. Pediatr Res 2006;59:801-5. (Pubitemid 44297632)
3. Shulenin S, Nogee LM, Annilo T, Wert SE, Whitsett JA, Dean M. ABCA3 gene mutations in newborns with fatal surfactant defciency. N Engl J Med 2004;350:1296-303. (Pubitemid 38375364)
4. Bullard JE, Wert SE, Whitsett JA, Dean M, Nogee LM. ABCA3 mutations associated with pediatric interstitial lung disease. Am J Respir Crit Care Med 2005;172:1026-31. (Pubitemid 41476541)
5. Karjalainen MK, Haataja R, Hallman M. Haplotype analysis of ABCA3: association with respiratory distress in very premature infants. Ann Med 2008;40:56-65. (Pubitemid 351197927)
6. Garmany TH, Wambach JA, Heins HB, et al. Population and disease-based prevalence of the common mutations associated with surfactant defciency. Pediatr Res 2008;63:645-9.
7. Hamvas A, Cole FS, Nogee LM. Genetic disorders of surfactant proteins. Neonatology 2007;91:311-7. (Pubitemid 46934217)
8. Bækvad-Hansen M, Nordestgaard BG, Dahl M. Heterozygosity for E292V in ABCA3, lung function and COPD in 64, 000 individuals. Respir Res 2012;13:67.
9. Wambach JA, Wegner DJ, Depass K, et al. Single ABCA3 mutations increase risk for neonatal respiratory distress syndrome. Pediatrics 2012;130:e1575-82.
10. Hammel M, Michel G, Hoefer C, et al. Targeted inactivation of the murine Abca3 gene leads to respiratory failure in newborns with defective lamellar bodies. Biochem Biophys Res Commun 2007;359:947-51. (Pubitemid 46946909)
11. Fitzgerald ML, Xavier R, Haley KJ, et al. ABCA3 inactivation in mice causes respiratory failure, loss of pulmonary surfactant, and depletion of lung phosphatidylglycerol. J Lipid Res 2007;48:621-32. (Pubitemid 46397465)
12. Cheong N, Zhang H, Madesh M, et al. ABCA3 is critical for lamellar body biogenesis in vivo. J Biol Chem 2007;282:23811-7. (Pubitemid 47328028)
13. Tokieda K, Iwamoto HS, Bachurski C, et al. Surfactant protein-B-defcient mice are susceptible to hyperoxic lung injury. Am J Respir Cell Mol Biol 1999;21:463-72. (Pubitemid 129504268)
14. Smith LJ. Hyperoxic lung injury: biochemical, cellular, and morphologic characterization in the mouse. J Lab Clin Med 1985;106:269-78. (Pubitemid 16118907)
15. Crapo JD. Morphologic changes in pulmonary oxygen toxicity. Annu Rev Physiol 1986;48:721-31. (Pubitemid 16047645)
16. dos Santos CC, Slutsky AS. Te contribution of biophysical lung injury to the development of biotrauma. Annu Rev Physiol 2006; 68: 585-618.
17. Veldhuizen EJ, Haagsman H P. Role of pulmonary surfactant components in surface flm formation and dynamics. Biochim Biophys Acta 2000;1467:255-70. (Pubitemid 30665581)
18. Hite RD, Seeds MC, Bowton DL, et al. Surfactant phospholipid changes afer antigen challenge: a role for phosphatidylglycerol in dysfunction. Am J Physiol Lung Cell Mol Physiol 2005;288:L610-7.
19. Tschumperlin DJ, Drazen JM. Chronic efects of mechanical force on airways. Annu Rev Physiol 2006;68:563-83.
20. Zemans RL, Matthay MA. Bench-to-bedside review: the role of the alveolar epithelium in the resolution of pulmonary edema in acute lung injury. Crit Care 2004;8:469-77. (Pubitemid 40073682)
21. Besnard V, Matsuzaki Y, Clark J, et al. Conditional deletion of Abca3 in alveolar type II cells alters surfactant homeostasis in newborn and adult mice. Am J Physiol Lung Cell Mol Physiol 2010;298:L646-59.
22. Riley DJ, Kramer MJ, Kerr JS, Chae CU, Yu SY, Berg RA. Damage and repair of lung connective tissue in rats exposed to toxic levels of oxygen. Am Rev Respir Dis 1987;135:441-7. (Pubitemid 17012111)
23. Xu Y, Saegusa C, Schehr A, Grant S, Whitsett JA, Ikegami M. C/EBP{alpha} is required for pulmonary cytoprotection during hyperoxia. Am J Physiol Lung Cell Mol Physiol 2009;297:L286-98.
24. Brasch F, Schimanski S, Mühlfeld C, et al. Alteration of the pulmonary surfactant system in full-term infants with hereditary ABCA3 defciency. Am J Respir Crit Care Med 2006;174:571-80. (Pubitemid 44330551)
25. Bullard JE, Nogee LM. Heterozygosity for ABCA3 mutations modifes the severity of lung disease associated with a surfactant protein C gene (SFTPC) mutation. Pediatr Res 2007;62:176-9. (Pubitemid 47205717)
26. Mahavadi P, Korfei M, Henneke I, et al. Epithelial stress and apoptosis underlie Hermansky-Pudlak syndrome-associated interstitial pneumonia. Am J Respir Crit Care Med 2010;182:207-19.
27. Liebisch G, Lieser B, Rathenberg J, Drobnik W, Schmitz G. High-throughput quantifcation of phosphatidylcholine and sphingomyelin by electro-spray ionization tandem mass spectrometry coupled with isotope correction algorithm. Biochim Biophys Acta 2004;1686:108-17. (Pubitemid 39446883)
28. Leidl K, Liebisch G, Richter D, Schmitz G. Mass spectrometric analysis of lipid species of human circulating blood cells. Biochim Biophys Acta 2008;1781:655-64.
29. Brügger B, Erben G, Sandhof R, Wieland FT, Lehmann WD. Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry. Proc Natl Acad Sci USA 1997;94:2339-44. (Pubitemid 27136876)
30. Matyash V, Liebisch G, Kurzchalia T V, Shevchenko A, Schwudke D. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J Lipid Res 2008;49:1137-46.
31. Flemmer AW, Jani JC, Bergmann F, et al. Lung tissue mechanics predict lung hypoplasia in a rabbit model for congenital diaphragmatic hernia. Pediatr Pulmonol 2007;42:505-12. (Pubitemid 46870381)
32. Lovgren AK, Jania LA, Hartney JM, et al. COX-2-derived prostacyclin protects against bleomycin-induced pulmonary fbrosis. Am J Physiol Lung Cell Mol Physiol 2006;291:L144-56.
33. Bates JH. Understanding lung tissue mechanics in terms of mathematical models. Monaldi Arch Chest Dis 1993;48:134-9. (Pubitemid 23198408)
34. Hantos Z, Daróczy B, Suki B, Nagy S, Fredberg JJ. Input impedance and peripheral inhomogeneity of dog lungs. J Appl Physiol 1992;72: 168-78.